This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Search results
-
Pfizer and the Challenges of the Pharmaceutical Industry (A)
Renate Kratochvil; Phillip C. NellCase IVEY-9B19M076-EStrategyIn 2018, President of the United States, Donald Trump, criticized the company Pfizer Inc. (Pfizer) for increasing drug prices—which had been a strategic move by Pfizer in response to industry-wide challenges. This announcement highlighted the complex dynaStarting at €8.20
-
Pfizer and the Challenges of the Pharmaceutical Industry (A) - Teaching Note
Renate Kratochvil; Phillip C. NellTeaching Note IVEY-8B19M076-EStrategyTeaching note for product 9B19M076.Starting at €0.00
-
Pfizer and the Challenges of the Pharmaceutical Industry (B) - Teaching Note
Renate Kratochvil; Phillip C. NellTeaching Note IVEY-8B19M077-EStrategyTeaching Note to accompany product 9B19M077.Starting at €0.00
-
Pfizer and the Challenges of the Pharmaceutical Industry (B)
Renate Kratochvil; Phillip C. NellCase IVEY-9B19M077-EStrategyCase B complements Case A, describing pharmaceutical companies’ strategic responses—such as mega-mergers and acquisitions and specialization—to industry-wide global challenges and highlights strategic decisions by Pfizer’s chief executive officers betweenStarting at €5.74
-
Internacionalization of Telefónica España, S.A. - Teaching Note
Ricart, Joan Enric; García Pont, Carlos; Knief C.Teaching Note DGT-15-ELeadership and People Management, StrategyStarting at €0.00
-
Internacionalización de Telefónica España, S.A. - Nota del Instructor
Ricart, Joan Enric; García Pont, Carlos; Knief C.Teaching Note DGT-15Leadership and People Management, Strategy(See case DG-1136)Starting at €0.00
-
Internationalization of Telefónica España S.A. - Case Update July 1996
Knief C.; Ricart, Joan Enric; García Pont, CarlosCase DG-1158-ELeadership and People Management, StrategyThis case recounts the history of Telefonica up until July 1996. Important developments since the first case include changes in the competitive environment due to new regulations at global and European level. In addition, Telefonica, SA is affected by changes in the Spanish government. The case describes how the changes affect Telefonica's businesses. It also informs about the final decision regarding the selection of a strategic alliance partner...Starting at €8.20
-
Internacionalización de Telefónica España, S.A.
Knief C.; García Pont, Carlos; Ricart, Joan EnricCase DG-1136Leadership and People Management, StrategyEl caso describe la competitividad y la estrategia del proveedor español de servicio de telecomunicación. Inicialmente, la compañía tenía un monopolio y operaba en el mercado español. Debido a la innovación tecnológica y a la desregulación del sector en muchos países, el entorno competitivo ha cambiado radicalmente. Esta nueva situación ha conducido a más competencia y a la aparición de compañías multinacionales. También se ha observado una proli...Starting at €8.20
-
Internationalization of Telefónica España, S.A.
Knief C.; García Pont, Carlos; Ricart, Joan EnricCase DG-1136-ELeadership and People Management, StrategyThe case describes the competitive position and strategy of the Spanish telecommunication service provider. Initially, the company had a monopoly and operated in the Spanish market. Due to technological innovation and the re-regulation of the sector in many countries, the competitive environment of the industry has changed fundamentally. This has led to more competition and the emergence of multinational companies. Also, a proliferation of strate...Starting at €8.20
-
Managing a Severe Crisis: PharmaCorp in Ukraine
Phillip C. Nell; Renate Kratochvil; Patricia KlopfCase IVEY-9B17M085-EStrategyIn early 2015, the newly appointed country head of PharmaCorp’s operating unit in Ukraine faced internal and external challenges in managing the global pharmaceutical company’s operations in the crisis-ridden country. Since November 2013, Ukraine had undergone massive disruptions, including riots in Kiev, the annexation of Crimea by Russia, and a war in its easternmost region. Amid these economic and political turbulences, PharmaCorp Ukraine expe...Starting at €8.20